Dr. Thawani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 855-702-8222
Summary
- Thoracic oncologist interested in patient care, drug development and translational oncology
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2020 - 2023
Maimonides Medical CenterResidency, Internal Medicine, 2017 - 2020
Delhi University College of Medical SciencesClass of 2014
Certifications & Licensure
IL State Medical License 2023 - 2026
OR State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow Teaching Award OHSU Internal Medicine Residency, 2022
- Fellow Research Award OHSU Internal Medicine, 2022
- Abstract Achievement Award American Society of Hematology, 2021
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 18 citationsImmunotherapy in head and neck squamous cell carcinoma: An updated review.K Parmar, A Mohamed, E Vaish, R Thawani, J Cetnar
Cancer Treatment and Research Communications. 2022-01-01 - 25 citationsParaganglioma of the Head and Neck: A Review.Lyndsey Sandow, Rajat Thawani, Myung Sun Kim, Michael C Heinrich
Endocrine Practice. 2023-02-01 - 1 citationsCurrent perspectives of KRAS in non-small cell lung cancer.Ethan Harris, Rajat Thawani
Current Problems in Cancer. 2024-08-01
Press Mentions
Foreign PracticeNovember 17th, 2014
New Imaging Technology May Help Predict Aggressiveness of Lung CancerOctober 7th, 2018
A New Generation of Physicians Matures into Patient Safety LeadershipNovember 26th, 2020- Join now to see all
Grant Support
- ROS1 in chemopreventionNL Tartar Trust2022–Present
- Strategies to bypass intrinsic resistance in ROS1 rearranged non-small cell lung cancerMedical Research Foundation of Oregon2022–2023
- Resident Research grantMaimonides Research and Development Foundation2017–2018
- CIR Wellness GrantCommittee of Interns and ResidentsPresent
Committees
- Member, Global Policy and Partnerships Committee 2024 - Present
Professional Memberships
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Association for the Study of Lung CancerMember
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
